La Financiere de L'Echiquier’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
BG
La Financiere de L'Echiquier's NBIX Position: Q2 2024 in Review
La Financiere de L'Echiquier increased its Neurocrine Biosciences (NBIX) stake by 948% in Q2 2024, buying an estimated $2.73M and bringing the position to 22,015 shares worth $3.03M. The position accounts for 0.13% of the portfolio, ranked #54.
La Financiere de L'Echiquier first reported a position in NBIX in Q1 2024 and has held it in 2 quarters since. 595 funds tracked by Wall St. Rank hold NBIX as of Q2 2024.
- La Financiere de L'Echiquier held 22,015 shares of Neurocrine Biosciences worth $3.03M as of Q2 2024.
- La Financiere de L'Echiquier bought 19,915 Neurocrine Biosciences shares in Q2 2024, an estimated $2.73M.
- Neurocrine Biosciences made up 0.13% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #54 holding.
- La Financiere de L'Echiquier first reported a position in Neurocrine Biosciences in Q1 2024 and has held it in 2 quarters since.
- 595 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2024.
Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.